Attention: Business/Financial Editors- Medipattern™ Corporation Appoints John Hughes as Chief Financial Officer
Published: Jan 29, 2010
TORONTO, ONTARIO--(Marketwire - January 29, 2010) - The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE: MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, today announced that John Hughes has been appointed chief financial officer (CFO) of the Company effective February 1, 2010. Mr. Hughes will replace Mark Greenspan, who has served as CFO and a member of the board of directors of Medipattern since 2002. Mr. Greenspan will continue to serve as a director of the Company.
Mr. Hughes brings a considerable amount of business experience to Medipattern, including experience with small start-ups to large multi stakeholder private and international public companies. Prior to joining Medipattern, Mr. Hughes was in private practice, servicing a variety of clients in public accounting, developing refinancing strategies, and business plan formation and implementation. Most recently, Mr. Hughes served as director, co-chief executive officer, and CFO of Recapture Metals Limited, a producer, recycler and refiner of high value minor metals and compounds for application in the technology sector, where his responsibilities included balance sheet management, refinancing strategies, full global P&L accountability, sales, reporting to external shareholders and the board, global treasury, international tax planning, risk and credit management, IT and corporate development. Mr. Hughes gained considerable international experience while with SGS Canada Inc., a leading global inspection, verification, testing and certification company, servicing the resource sector, where he served in various senior management roles and was eventually promoted to Managing Director Canada. Mr. Hughes began his career at Price Waterhouse Coopers (nee Coopers & Lybrand) Chartered Accountants, and gained extensive capital market experience while serving as CFO and treasurer at the investment banking firm Loewen, Ondaatje, McCutcheon Inc. He is a Chartered Accountant and earned a B.A. in Economics from Queens University.
"On behalf of the board of directors of Medipattern, I would like to welcome John to the team and look forward to working with him as we continue to expand the markets for our award winning products," stated Jeff Collins, President and CEO of Medipattern. "I would also like to recognize Mark for all his contributions to Medipattern during his time as CFO. He is a valued asset and we look forward to his continued support as a member of the board of directors and audit committee."
About The Medipattern Corporation:
Medipattern® (TSX VENTURE: MKI) is a pioneer in the development of medical software solutions that help improve imaging workflow and productivity. Our first-to-market, award-winning B-CAD® advances breast ultrasound computer aided detection (CAD) by streamlining workflow and organizing information into a comprehensive patient record. Medipattern uses its Cadenza™ CAD Technology to power the digital conversion in medical communications. B-CAD automatically creates fully digital standardized worksheets and reports that make every practice more efficient, productive and ultimately more effective. For more information, please visit the Company's website at: www.medipattern.com.
B-CAD® and Medipattern® are a registered mark of The Medipattern Corporation.
This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential", and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The Medipattern Corporation
(416) 744-0009 ext. 224
Spinnaker Capital Markets Inc.
(416) 962-3300 ext. 226